The MedCity CONVERGE conference in Philadelphia on July 11-12 will take a closer look at how companies like Deep 6 AI are making their mark at the intersection of artificial intelligence and cancer care.
In a recent phone interview, CONVERGE panelist Wout Brusselaers explained how his company comes into play. He co-founded and serves as CEO of Pasadena, California-based Deep 6 AI, a startup that utilizes AI to help with patient recruitment for clinical trials.
Where do AI and oncology converge?
ليست هناك تعليقات:
إرسال تعليق